Pharmacokinetics of Aripiprazole and Concomitant Lithium and Valproate

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of clinical pharmacology

• Publication date

  2005-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0091270004269870PMID 15601809
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Schizophrenia and valproate.

  2015cited by this paper
• Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study.

  2004cited by this paper
• Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology

  2003cited by this paper
• Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia

  2003cited by this paper
• Mood stabilisers plus risperidone or placebo in the treatment of acute mania

  2003cited by this paper
• Aripiprazole: A New Atypical Antipsychotic Drug

  2003cited by this paper
• Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.

  2002cited by this paper
• Datapoints: Use of Mood Stabilizers Among Patients With Schizophrenia, 1994-2001

  2002cited by this paper
• A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania.

  2002cited by this paper
• Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

  2002cited by this paper
• Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.

  2000cited by this paper
• The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study.

  2000cited by this paper
• Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.

  1999cited by this paper
• A Mechanistic Approach to Antiepileptic Drug Interactions

  1998cited by this paper
• Drugs and the treatment of psychiatric disorders

  1996cited by this paper
• Effect of valproic acid, its unsaturated metabolites and some structurally related fatty acids on the binding of warfarin and dansylsarcosine to human albumin.

  1991cited by this paper
• Differential effects of valproic acid on the serum protein binding of lorazepam and diazepam.

  1986cited by this paper
• Goodman and Gilman's the Pharmacological Basis of Therapeutics

  1986cited by this paper
• Goodman & Gilman's The Pharmacological Basis of Therapeutics

  1985cited by this paper
• INTERACTION BETWEEN PHENYTOIN AND VALPROATE

  1980cited by this paper

• Verification of successful maintenance by serum drug level during a guided antipsychotic reduction to reach minimum effective dose (GARMED) trial

  2024cites this paper
• Challenging pharmacotherapy management of a psychotic disorder due to a delicate pharmacogenetic profile and drug-drug interactions: a case report and literature review

  2024cites this paper
• Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes - detailed studies on CYP3A inhibitors.

  2024cites this paper
• Drug-drug interactions between antiseizure medications and antipsychotic medications: a narrative review and expert opinion

  2023cites this paper
• Fixed Dose Combination Tablets of Aripiprazole and Divalproex Sodium: a Pilot Pharmacokinetic Study in Human Volunteers

  2022cites this paper
• The impact of ibuprofen on valproic acid plasma concentration in pediatric patients

  2022cites this paper
• Racial/Ethnic Differences in the Pharmacokinetics of Antipsychotics: Focusing on East Asians

  2022cites this paper
• Psychotropic Drugs

  2022cites this paper
• Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics

  2022influential citation
• Published population pharmacokinetic models of valproic acid in adult patients: a systematic review and external validation in a Chinese sample of inpatients with bipolar disorder

  2022cites this paper
• Pharmacokinetic Interactions Between Antiseizure and Psychiatric Medications

  2022cites this paper
• Effects of the combination of second-generation antipsychotics on serum concentrations of aripiprazole and dehydroaripiprazole in Chinese patients with schizophrenia

  2021cites this paper
• Halogen Bonding: Types and Role in Biological Activities of Halogenated Molecules

  2021cites this paper
• Olanzapine-Related Somnambulism

  2021cites this paper
• Valproic acid autoinduction: a case-based review

  2021cites this paper
• The Impact of Smoking, Sex, Infection, and Comedication Administration on Oral Olanzapine: A Population Pharmacokinetic Model in Chinese Psychiatric Patients

  2021cites this paper
• Open channel block of Kv1.4 potassium channels by aripiprazole

  2020cites this paper
• Serum Aripiprazole Concentrations Prehemodialysis and Posthemodialysis in a Schizophrenic Patient With Chronic Renal Failure: A Case Report.

  2020cites this paper
• A safety evaluation of aripiprazole in the treatment of schizophrenia

  2020cites this paper
• Serum Aripiprazole Concentrations Prehemodialysis and Posthemodialysis in a Schizophrenic Patient With Chronic Renal Failure A Case Report

  2020cites this paper
• Comedication of Valproic Acid Is Associated With Increased Metabolism of Clozapine

  2018cites this paper
• Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder

  2018cites this paper
• Therapeutic Drug Monitoring of Second-Generation Antipsychotics for the Estimation of Early Drug Effect in First-Episode Psychosis: A Cross-sectional Assessment

  2018cites this paper
• Clinical Pharmacokinetics of Atypical Antipsychotics: An Update

  2018influential citation
• Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers

  2018cites this paper
• Aripiprazole: A New Option in Delirium

  2017cites this paper
• Caution in Co-administration of Aripiprazole and Lithium in Patients with Learning Disability

  2017cites this paper
• Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics.

  2016cites this paper
• Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics

  2016cites this paper
• Reduction in serum concentration of valproic acid secondary to the intake of ibuprofen as an example of valproic acid auto-induction metabolism.

  2016cites this paper
• Reducción en la concentración sérica del ácido valproico secundaria a la toma de ibuprofeno como ejemplo de autoinducción metabólica del ácido valproico

  2016cites this paper
• Dosing Recommendations of Aripiprazole Depot with Strong Cytochrome P450 3A4 Inhibitors: A Relapse Risk

  2016cites this paper
• The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.

  2015cites this paper
• Three Patients Needing High Doses of Valproic Acid to Get Therapeutic Concentrations

  2015cites this paper
• The effects of antiepileptic inducers in neuropsychopharmacology, a neglected issue. Part I: A summary of the current state for clinicians

  2015cites this paper
• The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients.

  2015cites this paper
• The effects of antiepileptic inducers in neuropsychopharmacology, a neglected issue. Part I: A summary of the current state for clinicians.

  2015cites this paper
• Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs.

  2014cites this paper
• False-Negative Studies May Systematically Contaminate the Literature on the Effects of Inducers in Neuropsychopharmacology. Part I: Focus on Epilepsy

  2014cites this paper
• Can Valproic Acid be an Inducer of Clozapine Metabolism?

  2014cites this paper
• Effect of valproate on the plasma concentrations of aripiprazole in bipolar patients

  2014influential citation
• False-Negative Studies May Systematically Contaminate the Literature on the Effects of Inducers in Neuropsychopharmacology: Part II Focus on Bipolar Disorder

  2014cites this paper
• Clinical pharmacology of atypical antipsychotics: an update

  2014cites this paper
• Clinical pharmacology of dopamine-modulating agents in Tourette's syndrome.

  2013cites this paper
• Metabolic Effects of Sodium Valproate on Atypical Antipsychotics in Japanese Psychotic Patients

  2013cites this paper
• A case report that suggested that aspirin's effects on valproic acid metabolism may contribute to valproic acid's inducer effects on clozapine metabolism.

  2013cites this paper
• Clinically Significant Drug Interactions with Atypical Antipsychotics

  2013cites this paper
• Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder.

  2012cites this paper
• Inhibitory Metabolic Drug Interactions with Newer Psychotropic Drugs: Inclusion in Package Inserts and Influences of Concurrence in Drug Interaction Screening Software

  2012cites this paper
• Interactions between antiepileptics and second-generation antipsychotics

  2012cites this paper
• Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance

  2012influential citation
• Aripiprazole: a review of its use in the management of schizophrenia in adults.

  2012cites this paper
• Lack of a pharmacokinetic drug–drug interaction between lithium and valproate when co‐administered with aripiprazole

  2012cites this paper
• with aripiprazole in humans Discriminative stimulus , subject-rated and cardiovascular effects of cocaine alone and in combination

  2011influential citation
• Aripiprazole: A Review of its Use in the Treatment of Irritability Associated with Autistic Disorder Patients Aged 6–17

  2011cites this paper
• Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans

  2011influential citation
• Aripiprazole and Dehydroaripiprazole Plasma Concentrations and Clinical Responses in Patients With Schizophrenia

  2011cites this paper
• A systematic review of aripiprazole--dose, plasma concentration, receptor occupancy, and response: implications for therapeutic drug monitoring.

  2010cites this paper
• Aripiprazole in Acute Mania and Long-Term Treatment of Bipolar Disorder

  2010cites this paper
• Computational note on IR and Raman spectra of neutral and protonated forms of Aripiprazole (Abilify) and its metabolite Dehydroaripiprazole

  2010cites this paper
• Die Therapie der akuten Manie mit Aripiprazol

  2010influential citation
• Influence of Comedication on Serum Concentrations of Aripiprazole and Dehydroaripiprazole

  2009cites this paper
• A liquid chromatography-electrospray ionization-tandem mass spectrometry method for quantitation of aripiprazole in human plasma.

  2009cites this paper
• Treatment and prevention of mania in bipolar I disorder: focus on aripiprazole

  2009cites this paper
• A UK consensus on the administration of aripiprazole for the treatment of mania

  2009cites this paper
• A non‐randomized study to investigate the effects of the atypical antipsychotic aripiprazole on the steady‐state pharmacokinetics of lamotrigine in patients with bipolar I disorder

  2009cites this paper
• Combination of aripiprazole and other psychopharmacological treatments in resistant and multi-resistant patients.

  2008cites this paper
• Population pharmacokinetic modelling of aripiprazole and its active metabolite, dehydroaripiprazole, in psychiatric patients.

  2008cites this paper
• Adjunct extended‐release valproate semisodium in late life schizophrenia

  2008cites this paper
• [Advances in the treatment of mania: aripiprazole].

  2008cites this paper
• Aripiprazol'ün Farmakodinamik ve Farmakokinetik Özellikleri

  2008cites this paper
• Effect of Co-medication on the Serum Concentrations of Aripiprazole and the Main Metabolite Dehydroaripiprazole

  2007cites this paper
• Clinical Pharmacokinetics of Atypical Antipsychotics

  2007cites this paper
• ABILIFY®, aripiprazole : premier agoniste partiel dans le traitement de la schizophrénie

  2007cites this paper
• Effects of Comedication on the Serum Levels of Aripiprazole: Evidence from a Routine Therapeutic Drug Monitoring Service

  2007cites this paper
• Metabolic drug interactions with newer antipsychotics: a comparative review.

  2007cites this paper
• Pharmacokinetics of Aripiprazole and Concomitant Carbamazepine

  2007cites this paper
• Interactions between Antiepileptic and Antipsychotic Drugs

  2006cites this paper
• A review of aripiprazole in the treatment of patients with schizophrenia or bipolar I disorder

  2006cites this paper
• Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.

  2006cites this paper
• Pharmacokinetic Variability of Aripiprazole and the Active Metabolite Dehydroaripiprazole in Psychiatric Patients

  2006cites this paper
• Role of aripiprazole in treating mood disorders

  2006cites this paper
• Aripiprazole: an appraisal of the translation of complex receptor effects into clinical outcomes

  2005cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2005cites this paper
• Current awareness in human psychopharmacology

  2005cites this paper
• Aripiprazole

  2005cites this paper
• Current awareness in human psychopharmacology.

  2005cites this paper
• Expert opinion

  2003cites this paper
• This item is the archived peer-reviewed author-version of: Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder

  year unknowncites this paper
• The Effects of Antiepileptic Inducers in Neuropsychopharmacology, a Neglected Issue. Part I: a Summary of the Current State for Clinicians Palabras Clave

  year unknowncites this paper